These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29759635)

  • 1. Nonsustained Ventricular Tachycardia at the Time of Implantation Predicts Appropriate Therapies on Rapid Ventricular Arrhythmia in Primary Prevention Patients With Nonischemic Cardiomyopathy: Results From the Very-High-Rate Registry.
    Clementy N; Bisson A; Challal F; Andre C; Pierre B; Fauchier L; Babuty D
    JACC Clin Electrophysiol; 2017 Nov; 3(11):1338-1339. PubMed ID: 29759635
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of ICD programming on inappropriate and appropriate ICD Therapies in ischemic and nonischemic cardiomyopathy: the MADIT-RIT trial.
    Sedláček K; Ruwald AC; Kutyifa V; McNitt S; Thomsen PEB; Klein H; Stockburger M; Wichterle D; Merkely B; DE LA Concha JF; Swissa M; Zareba W; Moss AJ; Kautzner J; Ruwald MH;
    J Cardiovasc Electrophysiol; 2015 Apr; 26(4):424-433. PubMed ID: 25546486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragmented QRS Is a Novel Risk Factor for Ventricular Arrhythmic Events After Receiving Cardiac Resynchronization Therapy in Nonischemic Cardiomyopathy.
    Igarashi M; Tada H; Yamasaki H; Kuroki K; Ishizu T; Seo Y; Machino T; Murakoshi N; Sekiguchi Y; Noguchi Y; Nogami A; Aonuma K
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):327-335. PubMed ID: 27925329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interlead heterogeneity of R- and T-wave morphology in standard 12-lead ECGs predicts sustained ventricular tachycardia/fibrillation and arrhythmic death in patients with cardiomyopathy.
    Tan AY; Nearing BD; Rosenberg M; Nezafat R; Josephson ME; Verrier RL
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1324-1333. PubMed ID: 28675579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of spontaneous recurrent ventricular arrhythmias detected by electrogram-storing defibrillators in sudden cardiac death survivors with no inducible ventricular arrhythmias at baseline electrophysiologic testing.
    Zaim S; Zaim B; Rottman J; Mendoza I; Nasir N; Pacifico A
    Am Heart J; 1996 Aug; 132(2 Pt 1):274-9. PubMed ID: 8701887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
    Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ;
    Eur Heart J; 2015 Nov; 36(41):2793-2867. PubMed ID: 26320108
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis.
    Varr BC; Zarafshar S; Coakley T; Liedtke M; Lafayette RA; Arai S; Schrier SL; Witteles RM
    Heart Rhythm; 2014 Jan; 11(1):158-62. PubMed ID: 24121001
    [No Abstract]   [Full Text] [Related]  

  • 13. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for implantable cardioverter-defibrillator placement in ischemic cardiomyopathy and after myocardial infarction.
    Mountantonakis SE; Hutchinson MD
    Curr Heart Fail Rep; 2011 Dec; 8(4):252-9. PubMed ID: 21769565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Term Variability of the QT Interval Can be Used for the Prediction of Imminent Ventricular Arrhythmias in Patients With Primary Prophylactic Implantable Cardioverter Defibrillators.
    Smoczyńska A; Loen V; Sprenkeler DJ; Tuinenburg AE; Ritsema van Eck HJ; Malik M; Schmidt G; Meine M; Vos MA
    J Am Heart Assoc; 2020 Dec; 9(23):e018133. PubMed ID: 33215550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracardiac alternans compared to surface T-wave alternans as a predictor of ventricular arrhythmias in humans.
    Sandhu RK; Costantini O; Cummings JE; Poelzing S; Rosenbaum DS; Quan KJ
    Heart Rhythm; 2008 Jul; 5(7):1003-8. PubMed ID: 18598955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
    Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhythm disorders in isolated left ventricular noncompaction.
    Steffel J; Duru F
    Ann Med; 2012 Mar; 44(2):101-8. PubMed ID: 21639721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.